• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

放射性碘化碘苯甲酸N-琥珀酰亚胺酯的合成:用于抗体标记的优化方法。

Synthesis of radioiodinated N-succinimidyl iodobenzoate: optimization for use in antibody labelling.

作者信息

Garg P K, Archer G E, Bigner D D, Zalutsky M R

机构信息

Department of Radiology, Duke University Medical Center, Durham, NC 27710.

出版信息

Int J Rad Appl Instrum A. 1989;40(6):485-90. doi: 10.1016/0883-2889(89)90131-7.

DOI:10.1016/0883-2889(89)90131-7
PMID:2551846
Abstract

N-succinimidyl-3-(tri-n-butylstannyl)benzoate (m-BuATE), N-succinimidyl-3-(tri-methylstannyl)benzoate (m-MeATE) and N-succinimidyl-4-(tri-n-butylstannyl)benzoate (p-BuATE) were synthesized and radioiodinated using either N-chlorosuccinimide (NCS) or t-butylhydroperoxide (TBHP) as the oxidant. Radiohalogenation of m-MeATE proceeded more rapidly than m-BuATE. NCS was the more efficient oxidant at reaction times less than 15 min; use of both TBHP and NCS resulted in nearly quantitative yields after 15 min when m-MeATE was used. Using NCS, achieving optimal antibody coupling and specific binding required purification of the active ester by HPLC; in contrast, with TBHP, only Sep-Pak purification was needed.

摘要

合成了N-琥珀酰亚胺基-3-(三正丁基锡基)苯甲酸酯(间-丁基ATE)、N-琥珀酰亚胺基-3-(三甲基锡基)苯甲酸酯(间-甲基ATE)和N-琥珀酰亚胺基-4-(三正丁基锡基)苯甲酸酯(对-丁基ATE),并使用N-氯代琥珀酰亚胺(NCS)或叔丁基过氧化氢(TBHP)作为氧化剂进行放射性碘化。间-甲基ATE的放射性卤化比间-丁基ATE进行得更快。在反应时间少于15分钟时,NCS是更有效的氧化剂;当使用间-甲基ATE时,在15分钟后同时使用TBHP和NCS可获得几乎定量的产率。使用NCS时,通过高效液相色谱法(HPLC)纯化活性酯才能实现最佳的抗体偶联和特异性结合;相比之下,使用TBHP时,仅需Sep-Pak纯化。

相似文献

1
Synthesis of radioiodinated N-succinimidyl iodobenzoate: optimization for use in antibody labelling.放射性碘化碘苯甲酸N-琥珀酰亚胺酯的合成:用于抗体标记的优化方法。
Int J Rad Appl Instrum A. 1989;40(6):485-90. doi: 10.1016/0883-2889(89)90131-7.
2
N-succinimidyl 4-methyl-3-(tri-n-butylstannyl)benzoate: synthesis and potential utility for the radioiodination of monoclonal antibodies.
Nucl Med Biol. 1993 May;20(4):379-87. doi: 10.1016/0969-8051(93)90067-5.
3
Radiohalogenation of a monoclonal antibody using an N-succinimidyl 3-(tri-n-butylstannyl)benzoate intermediate.使用N-琥珀酰亚胺基3-(三正丁基锡基)苯甲酸酯中间体对单克隆抗体进行放射性卤化。
Cancer Res. 1988 Mar 15;48(6):1446-50.
4
Radioiodination of antibodies via N-succinimidyl 2,4-dimethoxy-3-(trialkylstannyl)benzoates.通过N-琥珀酰亚胺基2,4-二甲氧基-3-(三烷基锡基)苯甲酸酯对抗体进行放射性碘化。
Bioconjug Chem. 1990 Nov-Dec;1(6):387-93. doi: 10.1021/bc00006a004.
5
Preparation of N-succinimidyl 3-[*I]iodobenzoate: an agent for the indirect radioiodination of proteins.N-琥珀酰亚胺基-3-[¹²⁵I]碘苯甲酸酯的制备:一种用于蛋白质间接放射性碘化的试剂。
Nat Protoc. 2006;1(2):707-13. doi: 10.1038/nprot.2006.99.
6
Optimization of radioiodination and biotinylation of monoclonal antibody chimeric BR96: an indirect labeling using N-succinimidyl-3-(tri-n-butylstannyl)benzoate conjugate.单克隆抗体嵌合体BR96的放射性碘化和生物素化优化:使用N-琥珀酰亚胺基-3-(三正丁基锡基)苯甲酸酯共轭物的间接标记
Cancer Biother Radiopharm. 1996 Jun;11(3):217-26. doi: 10.1089/cbr.1996.11.217.
7
Radioimmunotherapy of breast cancer xenografts with monoclonal antibody ICR12 against c-erbB2 p185: comparison of iodogen and N-succinimidyl 4-methyl-3-(tri-n-butylstannyl)benzoate radioiodination methods.用抗c-erbB2 p185单克隆抗体ICR12对乳腺癌异种移植瘤进行放射免疫治疗:碘代甘氨酸法与N-琥珀酰亚胺基-4-甲基-3-(三正丁基锡基)苯甲酸酯放射性碘化方法的比较
Cancer Res. 1995 Dec 1;55(23 Suppl):5842s-5846s.
8
Synthesis and radioiodination of N-Boc-p-(tri-n-butylstannyl)-L-phenylalanine tetrafluorophenyl ester: preparation of a radiolabeled phenylalanine derivative for peptide synthesis.N-叔丁氧羰基-p-(三正丁基锡基)-L-苯丙氨酸四氟苯酯的合成与放射性碘化:用于肽合成的放射性标记苯丙氨酸衍生物的制备
Bioconjug Chem. 1993 Nov-Dec;4(6):574-80. doi: 10.1021/bc00024a024.
9
Chloramine-T in high-specific-activity radioiodination of antibodies using N-succinimidyl-3-(trimethylstannyl)benzoate as an intermediate.使用N-琥珀酰亚胺基-3-(三甲基锡基)苯甲酸酯作为中间体,在抗体的高比活放射性碘化中使用氯胺-T。
Nucl Med Biol. 1998 Oct;25(7):659-65. doi: 10.1016/s0969-8051(98)00033-x.
10
Astatination of proteins using an N-succinimidyl tri-n-butylstannyl benzoate intermediate.使用N-琥珀酰亚胺基三正丁基锡苯甲酸酯中间体对蛋白质进行砹化。
Int J Rad Appl Instrum A. 1988;39(3):227-32. doi: 10.1016/0883-2889(88)90176-1.

引用本文的文献

1
Covalent core-radiolabeling of polymeric micelles with I/At for theranostic radiotherapy.利用 I/At 对聚合物胶束进行共价核标记用于治疗性放射治疗。
Nanotheranostics. 2022 Jul 18;6(4):388-399. doi: 10.7150/ntno.71906. eCollection 2022.
2
Labeling Monoclonal Antibody with α-emitting At at High Activity Levels via a Tin Precursor.通过锡前体以高比活度对单克隆抗体进行α放射性标记。
Cancer Biother Radiopharm. 2020 Sep;35(7):511-519. doi: 10.1089/cbr.2019.3204. Epub 2020 Feb 28.
3
Radiopharmaceutical chemistry of targeted radiotherapeutics, part 4: Strategies for At labeling at high activities and radiation doses of At α-particles.
靶向放射治疗的放射性药物化学,第4部分:在高活度和高辐射剂量下进行砹标记以产生α粒子的策略。
Nucl Med Biol. 2017 Mar;46:43-49. doi: 10.1016/j.nucmedbio.2016.11.009. Epub 2016 Dec 10.
4
Shelf-life of ɛ-lysyl-3-(trimethylstannyl)benzamide immunoconjugates, precursors for 211At labeling of antibodies.用于211At标记抗体的前体——ɛ-赖氨酸-3-(三甲基锡基)苯甲酰胺免疫缀合物的保质期。
Cancer Biother Radiopharm. 2015 Feb;30(1):41-5. doi: 10.1089/cbr.2014.1729. Epub 2015 Jan 14.
5
N-Succinimidyl guanidinomethyl iodobenzoate protein radiohalogenation agents: influence of isomeric substitution on radiolabeling and target cell residualization.N-琥珀酰亚胺基碘苯甲酸胍甲基蛋白质放射性卤化剂:异构体取代对放射性标记和靶细胞滞留的影响。
Nucl Med Biol. 2014 Nov-Dec;41(10):802-12. doi: 10.1016/j.nucmedbio.2014.07.005. Epub 2014 Aug 1.
6
SIB-DOTA: a trifunctional prosthetic group potentially amenable for multi-modal labeling that enhances tumor uptake of internalizing monoclonal antibodies.SIB-DOTA:一种三功能的前体药物,可能适用于多模态标记,增强内化单克隆抗体在肿瘤中的摄取。
Bioorg Med Chem. 2012 Dec 15;20(24):6929-39. doi: 10.1016/j.bmc.2012.10.025. Epub 2012 Oct 29.
7
Reagents for astatination of biomolecules. 4. Comparison of maleimido-closo-decaborate(2-) and meta-[(211)At]astatobenzoate conjugates for labeling anti-CD45 antibodies with [(211)At]astatine.用于生物分子标记的放射性碘试剂。4. 马来酰亚胺-closo-癸硼酸盐(2-)和间-[(211)At]放射性碘代苯甲酸酯缀合物在标记抗 CD45 抗体时的比较。
Bioconjug Chem. 2009 Oct 21;20(10):1983-91. doi: 10.1021/bc9000799. Epub 2009 Sep 4.
8
In vitro selectivity, in vivo biodistribution and tumour uptake of annexin V radiolabelled with a positron emitting radioisotope.
Br J Cancer. 2003 Oct 6;89(7):1327-33. doi: 10.1038/sj.bjc.6601262.
9
Analysis of the therapeutic gain in the treatment of human osteosarcoma microcolonies in vitro with 211At-labelled monoclonal antibody.用211At标记的单克隆抗体体外治疗人骨肉瘤微集落的治疗增益分析。
Br J Cancer. 1994 Jun;69(6):1000-5. doi: 10.1038/bjc.1994.196.
10
Labeling monoclonal antibodies and F(ab')2 fragments with the alpha-particle-emitting nuclide astatine-211: preservation of immunoreactivity and in vivo localizing capacity.用发射α粒子的核素砹-211标记单克隆抗体和F(ab')2片段:免疫反应性和体内定位能力的保留
Proc Natl Acad Sci U S A. 1989 Sep;86(18):7149-53. doi: 10.1073/pnas.86.18.7149.